Dr. Ravi Munver

Dr. Ravi Munver
Dr. Munver received his undergraduate education at Cornell University where he graduated magna cum laude and Phi Beta Kappa with a B.A. from the College Scholar Honors Program. He received his medical education at Cornell University Medical College and completed residency training in general surgery and urology at Duke University Medical Center. He received advanced fellowship training in robotic, laparoscopic, and endoscopic surgery at New York-Presbyterian Hospital/Weill Cornell Medical Center. He is Board Certified as a Diplomate of the American Board of Urology and is was elected as a Fellow of the American College of Surgeons. Dr. Munver is Vice Chair and Director of Minimally Invasive and Robotic Urologic Surgery in the Department of Urology at Hackensack University Medical Center. He is Chief of Living Donor Kidney Surgery in the Division Organ Transplantation of the Department of Surgery. He is a Core Professor of Urology at Hackensack Meridian School of Medicine, and Adjunct Professor of Urology at Rutgers New Jersey Medical School. He is the founding Director of the Hackensack University Medical Center Endourology Fellowship Program, New Jersey’s first accredited Endourology Fellowship. Dr. Munver is an internationally renowned leader in robotic, laparoscopic, and endoscopic surgery. He has been recognized for his clinical expertise by America’s Top Urologists, Best Doctors in America, Castle Connolly Top Doctors-New York Metro Area, Inside Jersey Top Doctors, New Jersey Monthly Top Doctors, New York Magazine Best Doctors, Super Docs, and Top Cancer Doctors. Dr. Munver is a passionate academician and educator, and has lectured in 21 countries spanning 5 continents. His clinical interests include prostate enlargement, robotic surgery, minimally invasive urologic surgery, oncology (prostate, kidney, bladder, ureter, adrenal cancers), and kidney stones. In addition, Dr. Munver has a unique interest in optimizing clinical outcomes through innovation and technology. His extensive research has allowed him to develop a unique approach for the prevention and management of urologic complications. He teaches at national and international conferences and regularly serves on the faculty of courses sponsored by the American Urological Association and the Endourological Society. He has authored more than 500 scientific manuscripts, articles, book chapters, and abstracts. He has received awards from the National Institutes of Health (NIH), American Urological Association, Endourological Society, and Society of Laparoscopic and Robotic Surgeons. Dr. Munver has mentored more than 40 medical students, 50 residents, and 15 fellows as an attending physician. He has previously held the position of Coordinator of Urologic Education in the Department of Urology at Hackensack University Medical Center. Dr. Munver is known for his compassionate care with patients and has received the Gold DOC Award for Humanism in Medicine. He was also awarded the Alpha Omega Alpha Volunteer Clinical Faculty Award by the AOA National Honor Medical Society, and Golden Apple Award for excellence in teaching. He has been teaching graduate medical education for more than 20 years and he remains dedicated to student success. Dr. Munver’s entire career has been spent at prestigious academic institutions where he has held a number of leadership positions. He is also extremely active in the American Urological Association, the New York Section of the American Urological Association, Endourological Society, and Society of Laparoscopic and Robotic Surgeons.

Languages Spoken:

English, Spanish

Medical School:

Weill Cornell Medical College


Duke University Medical Center


New York Presbyterian-Weill Cornell Medicine


Cornell University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only